Stay updated on Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error screen (with 403 message and standard header/footer), reflecting an access issue rather than an update to the study information.
    Difference
    19%
    Check dated 2026-09-20T22:37:44.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-08-30T21:46:56.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.4 to v3.6.5, indicating a new minor revision of the page; this reflects an update to the page’s documentation rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-08-09T09:13:53.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page version and related metadata.
    Difference
    0.1%
    Check dated 2026-07-25T18:20:14.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This signals a new build of the page rendering, without altering the study details.
    Difference
    0.1%
    Check dated 2026-07-04T08:30:18.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    The page's revision tag was updated from Revision: v3.6.0 to Revision: v3.6.2, signaling a software version bump in the site metadata. This change does not modify study details, eligibility criteria, or any user-facing content.
    Difference
    0.1%
    Check dated 2026-06-27T06:26:58.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.